Advertisement

Index by author

August 01, 2010; Volume 38,Issue 8

  1. Akiyama, Yutaka

    1. In Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical Parameters
      Makiko Kusama, Kouta Toshimoto, Kazuya Maeda, Yuka Hirai, Satoki Imai, Koji Chiba, Yutaka Akiyama and Yuichi Sugiyama
      Drug Metabolism and Disposition August 2010, 38 (8) 1362-1370; DOI: https://doi.org/10.1124/dmd.110.032789

  2. Ambudkar, Suresh V.

    1. Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib
      Marius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. Bates
      Drug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302

  3. Argikar, Upendra A.

    1. Identification of Novel Metoclopramide Metabolites in Humans: In Vitro and In Vivo Studies
      Upendra A. Argikar, Javier Gomez, Din Ung, Henry P. Parkman and Swati Nagar
      Drug Metabolism and Disposition August 2010, 38 (8) 1295-1307; DOI: https://doi.org/10.1124/dmd.110.033357

  4. Baba, Kimiye

    1. Furanocoumarin Derivatives in Kampo Extract Medicines Inhibit Cytochrome P450 3A4 and P-Glycoprotein
      Kazunori Iwanaga, Manami Hayashi, Yukimi Hamahata, Makoto Miyazaki, Makio Shibano, Masahiko Taniguchi, Kimiye Baba and Masawo Kakemi
      Drug Metabolism and Disposition August 2010, 38 (8) 1286-1294; DOI: https://doi.org/10.1124/dmd.110.032847

  5. Bates, Susan E.

    1. Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib
      Marius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. Bates
      Drug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302

  6. Bies, Robert

    1. Methadone: A Substrate and Mechanism-Based Inhibitor of CYP19 (Aromatase)
      Wenjie Jessie Lu, Robert Bies, Landry K. Kamden, Zeruesenay Desta and David A. Flockhart
      Drug Metabolism and Disposition August 2010, 38 (8) 1308-1313; DOI: https://doi.org/10.1124/dmd.110.032474

  7. Boddy, Alan V.

    1. Relevance of Nonsynonymous CYP2C8 Polymorphisms to 13-cis Retinoic Acid and Paclitaxel Hydroxylation
      Sophie E. Rowbotham, Alan V. Boddy, Chris P. F. Redfern, Gareth J. Veal and Ann K. Daly
      Drug Metabolism and Disposition August 2010, 38 (8) 1261-1266; DOI: https://doi.org/10.1124/dmd.109.030866

  8. Boer, Jason

    1. Species-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological Implications
      Sharon Diamond, Jason Boer, Thomas P. Maduskuie, Nikoo Falahatpisheh, Yu Li and Swamy Yeleswaram
      Drug Metabolism and Disposition August 2010, 38 (8) 1277-1285; DOI: https://doi.org/10.1124/dmd.110.032375

  9. Brendel, Cornelia

    1. Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib
      Marius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. Bates
      Drug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302

  10. Chen, Xiaoyan

    1. Metabolism of Flumatinib, a Novel Antineoplastic Tyrosine Kinase Inhibitor, in Chronic Myelogenous Leukemia Patients
      Aishen Gong, Xiaoyan Chen, Pan Deng and Dafang Zhong
      Drug Metabolism and Disposition August 2010, 38 (8) 1328-1340; DOI: https://doi.org/10.1124/dmd.110.032326
« Previous (Pages : 1 2 3 4 5 6 ... 9) Next »
Back to top

In this issue

Advertisement